161 related articles for article (PubMed ID: 1646324)
1. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
Goldschmidt JE; Tallarida RJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):1136-45. PubMed ID: 1646324
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
[TBL] [Abstract][Full Text] [Related]
3. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
Liu YH; You Y; Song T; Wu SJ; Liu LY
J Cardiovasc Pharmacol; 2007 Aug; 50(2):155-61. PubMed ID: 17703131
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
Mollace V; Salvemini D; Sessa WC; Vane JR
J Pharmacol Exp Ther; 1991 Sep; 258(3):820-3. PubMed ID: 1716310
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
Jia L; Furchgott RF
J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
[TBL] [Abstract][Full Text] [Related]
6. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
7. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
Lawson DL; Nichols WW; Mehta P; Mehta JL
J Cardiovasc Pharmacol; 1991 Mar; 17(3):411-8. PubMed ID: 1711602
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta.
Andriambeloson E; Kleschyov AL; Muller B; Beretz A; Stoclet JC; Andriantsitohaina R
Br J Pharmacol; 1997 Mar; 120(6):1053-8. PubMed ID: 9134217
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
[TBL] [Abstract][Full Text] [Related]
11. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
Martin W; Furchgott RF; Villani GM; Jothianandan D
J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
[TBL] [Abstract][Full Text] [Related]
12. Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations.
Shultz PJ; Raij L
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):151S-157S. PubMed ID: 2557877
[TBL] [Abstract][Full Text] [Related]
13. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
Tesfamariam B
J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
[TBL] [Abstract][Full Text] [Related]
14. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.
Mittra S; Singh M
Mol Cell Biochem; 1998 Jun; 183(1-2):63-7. PubMed ID: 9655179
[TBL] [Abstract][Full Text] [Related]
16. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
Gräser T; Vedernikov YP
Biomed Biochim Acta; 1989; 48(4):351-3. PubMed ID: 2787633
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
Ignarro LJ; Byrns RE; Buga GM; Wood KS
Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
